{
    "nctId": "NCT04860115",
    "briefTitle": "Impact of Novel Thoracic Wall Blocks With Dexmetomidine on Inflammatory Markers Following Breast Cancer Surgery",
    "officialTitle": "Impact of Novel Thoracic Wall Blocks With Dexmetomidine on Inflammatory Markers Following Breast Cancer Surgery",
    "overallStatus": "UNKNOWN",
    "conditions": "Inflammatory Markers",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 120,
    "primaryOutcomeMeasure": "Difference in NLR",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female patients with ductal carcinoma (stage 1 to 3) undergoing primary potentially curative unilateral mastectomy.\n* Older than 18 years\n* ASA I-III\n\nExclusion Criteria:\n\n* Weight \\< 50 kg\n* BMI \\> 35\n* Allergy to local anaesthetic or dexmetomidine\n* Contraindications to NSAIDs use\n* Local infection over block site\n* Coagulopathy\n* Preexisting chronic pain\n* Pregnancy\n* Autoimmune disease\n* Inability to give informed consent",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}